Accel Pharmtech, LLC is a leading pharmaceutical company specializing in the manufacturing and supply of active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, custom synthesis, and contract research services. The company's catalog features a wide range of products, including derivatives of various compounds such as furan, oxazole, piperazine, pyridine, and boronic acid. With a focus on establishing strong business relationships, Accel Pharmtech, LLC targets customers in the pharmaceutical and biotech industries, research institutes, and universities globally, including in North America and China. The company was founded in 2010 and operates in the Manufacturing and Pharmaceutical industries. Overall, Accel Pharmtech, LLC emphasizes its commitment to "High Quality, Competitive Price, Timely Communications, and Fast Delivery," and welcomes collaboration with customers and vendors to achieve mutual benefits. While specific details regarding past investments and investors are not available, the company's dedication to quality and global reach position it as a potential player in the pharmaceutical manufacturing landscape.
There is no investment information
No recent news or press coverage available for Accel pharmtech.
We care about your data, and we'd love to use cookies make your experience better.
